Key result
Male sex, physical triggers, CKD, and malignancy are linked to higher Takotsubo cardiomyopathy mortality.
Why the study?
Due to incomplete understanding of pathophysiologic mechanisms in Takotsubo cardiomyopathy, evidence-based medical therapy is lacking, prompting a review of risk factors and therapies affecting outcomes.
What are the prognostic factors and effects of medical therapies on outcomes in patients with Takotsubo cardiomyopathy?
Population
Patients with Takotsubo cardiomyopathy
Comparison
Risk factors and medical therapies affecting outcome
Design
Systematic review
Authors
Loading...
May inform risk stratification in Takotsubo cardiomyopathy; leaves open survival benefits of heart failure therapies.
Systematic Review
What are the prognostic factors and effects of medical therapies on outcomes in patients with Takotsubo cardiomyopathy?
Male sex, physical triggers, and specific comorbidities are associated with poor prognosis in Takotsubo cardiomyopathy, whereas current evidence for survival benefits from standard heart failure medications remains limited.
Lu et al. (2021) conducted a systematic review in Takotsubo cardiomyopathy. Prognostic factors (e.g., male sex, physical triggers, comorbidities) was evaluated on Short-term and long-term mortality. Male sex, physical triggers, and certain comorbidities such as chronic kidney disease and malignant disease were associated with poor prognosis in patients with Takotsubo cardiomyopathy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: